Comerica Bank Bicycle Therapeutics PLC Transaction History

Comerica Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$20.02 - $24.69 $644,043 - $794,277	32,170 Added 40.84%	110,940 $2.25 Million
Q1 2024 May 15, 2024	SELL	$16.75 - $26.1 $51,590 - $80,388	-3,080 Reduced 3.76%	78,770 $1.96 Million
Q4 2023 Feb 14, 2024	BUY	$13.29 - $22.2 $1.08 Million - $1.81 Million	81,400 Added 18088.89%	81,850 $1.48 Million
Q3 2023 Nov 21, 2023	BUY	$19.9 - $26.25 $8,955 - $11,812	450 New	450 $9,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $419M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.